Puma Biotechnology, Inc. rose 2.99% in after-hours trading, with the company surging on a report of a takeover approach for the sportswear firm. European shares ended flat on Wednesday as investors avoided making big bets ahead of the Federal Reserve's monetary policy decision.
Comments
No comments yet